Sanofi (Germany)

Recent papers from Sanofi (Germany)

1. Rise of Lower Respiratory Tract Infections Other than Respiratory Syncytial Virus in the Emergency Room: Results from the Season (2024/25) of the RISE StudyInfectious Diseases and Therapy · 2026
2. Life cycle assessment of insulin products: Hotspots identification and opportunities for sustainable pharmacySustainable Chemistry and Pharmacy · 2026
3. Skeletal editing approach for 13C/14C-labeling of adenines via formal heteroaromatic carbon isotope exchange with carbon dioxideCommunications Chemistry · 2026
4. Quantitative assessment of contractility and electrophysiology drug-induced effects through human in silico simulationsJournal of Pharmacological and Toxicological Methods · 2026
5. Calibrating mathematical models of rabbit purkinje fibre electrophysiology to improve predictions of drug-induced action potential changesJournal of Pharmacological and Toxicological Methods · 2026
6. From Biological Mechanisms to Causal Inference: Quantitative Systems Pharmacology and Causal Frameworks in Drug DevelopmentClinical Pharmacology & Therapeutics · 2026
7. Exploration and validation of large language models as tools for molecular optimizationCommunications Chemistry · 2026
8. Tearing Down Scientific Boundaries: Frontiers in Medicinal Chemistry 2026ChemMedChem · 2026
9. Next-Generation GLP-1 Agonist Bioassays: Integrating Precision with Biological RelevanceInternational Journal of Molecular Sciences · 2026
10. Preserving beta cell function in children and adolescents with newly diagnosed stage 3 type 1 diabetes: per-protocol population analysis from the PROTECT randomised trialDiabetologia · 2026
11. Causal Inference and Pathway Embeddings with Real-World Data for Enhanced Trial Design Across DiseasesMathematical and Computational Applications · 2026
12. Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumorsJournal for ImmunoTherapy of Cancer · 2026
13. Dronedarone in patients with congestive heart failure: insights from ATHENAEuropean Heart Journal · 2010
14. The economic impact of pediatric RSV-related lower respiratory tract infection in Germany: evidence from the PAPI studyJournal of Medical Economics · 2026
15. Incorporating estimands into meta-analyses of clinical trialsResearch Synthesis Methods · 2026
16. SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site studyGene Therapy · 2026
17. Multimodal cheminformatic and network biology analysis enables deeper mechanistic understanding of PFAS-induced hepatotoxicityBMC Bioinformatics · 2026
18. Water‐Dispersible Ruthenium Nanocatalyst for Carbonyl Reduction With D ₂ or T ₂ in Aqueous MediaAngewandte Chemie International Edition · 2026
19. Water‐Dispersible Ruthenium Nanocatalyst for Carbonyl Reduction With D ₂ or T ₂ in Aqueous MediaAngewandte Chemie · 2026
20. The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric CancersCancer Research · 2026